MedPath
HSA Approval

METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500mg

SIN14594P

METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500mg

METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500mg

August 26, 2014

MYLAN PHARMACEUTICALS PTE. LTD.

MYLAN PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMYLAN PHARMACEUTICALS PTE. LTD.
Licence HolderMYLAN PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

H02AB04

methylprednisolone

Manufacturer Information

mylan pharmaceuticals pte. ltd.

Mylan Laboratories Limited [Specialty Formulation Facility]

Active Ingredients

Methylprednisolone sodium succinate 633.60mg equv Methylprednisolone

500mg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500mg - HSA Approval | MedPath